As expected with combination chemotherapy, the most common side effects included gastrointestinal and hematologic toxicities, and fatigue.

Source: https://www.prnewswire.com/news-releases/phase-3-swog-cancer-research-network-trial-led-by-a-city-of-hope-researcher-demonstrates-one-year-progression-free-survival-in-94-of-patients-with-stage-3-or-4-classic-hodgkin-lymphoma-who-received-a-checkpoint-inh

No unknown adverse events or toxicities were reported that could limit dosing during the studies.

Source: https://seekingalpha.com/article/4594930-kura-oncology-multiple-catalysts-provide-strong-upside-potential?source=feed_all_articles